Effect of depot medroxyprogesterone acetate on bone mineral density at the spine, hip and forearm.

被引:0
|
作者
Walsh, JS [1 ]
Eastell, R [1 ]
Peel, NF [1 ]
机构
[1] Univ Sheffield, Bone Metab Grp, Sheffield, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S369 / S369
页数:1
相关论文
共 50 条
  • [41] Effect of depot medroxyprogesterone acetate(DMPA) on bone mineral density(BMD) and evaluating changes in BMD after discontinuation of DMPA in adolescent women
    Cheng-wu SHEN
    Ling GAI
    Li-hong ZHANG
    Lin-lin WANG
    Hai-qing DING
    Hui JIANG
    Journal of Reproduction and Contraception, 2015, (03) : 151 - 159
  • [42] Comparison of normative data for skeletal assessment at the spine, hip and forearm.
    deTakats, D
    McCloskey, E
    Bernard, J
    Beneton, M
    Charlesworth, D
    Kanis, JA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S588 - S588
  • [43] Bone density recovery after depot medroxyprogesterone acetate injectable contraception use
    Kaunitz, Andrew M.
    Arias, Raquel
    McClung, Michael
    CONTRACEPTION, 2008, 77 (02) : 67 - 76
  • [44] Lumbar spine, hip and forearm bone mineral density in a group of Lebanese professional football players
    El Hage, R.
    Jaber, M.
    Jacob, C.
    Moussa, E.
    Theunynck, D.
    SCIENCE & SPORTS, 2013, 28 (04) : 204 - 206
  • [45] Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density
    Bruce Carr
    W. Paul Dmowski
    Chris O’Brien
    Ping Jiang
    Joshua Burke
    Roland Jimenez
    Elizabeth Garner
    Kristof Chwalisz
    Reproductive Sciences, 2014, 21 : 1341 - 1351
  • [46] Depot medroxyprogesterone acetate and bone mineral density in adolescents - The black box warning: A position paper of the society for adolescent medicine
    Cromer, Barbara A.
    Scholes, Delia
    Berenson, Abbey
    Cundy, Tim
    Clark, M. Kathleen
    Kaunitz, Andrew M.
    JOURNAL OF ADOLESCENT HEALTH, 2006, 39 (02) : 296 - 301
  • [47] Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception
    Beksinska, Mags E.
    Kleinschmidt, Immo
    Smit, Jenni A.
    Farley, Timothy M. M.
    CONTRACEPTION, 2007, 75 (06) : 438 - 443
  • [48] Elagolix, an Oral GnRH Antagonist, Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis: Effects on Bone Mineral Density
    Carr, Bruce
    Dmowski, W. Paul
    O'Brien, Chris
    Jiang, Ping
    Burke, Joshua
    Jimenez, Roland
    Garner, Elizabeth
    Chwalisz, Kristof
    REPRODUCTIVE SCIENCES, 2014, 21 (11) : 1341 - 1351
  • [49] Effect of osteoarthritis on spine and hip bone mineral density in the elderly.
    Liu, G
    Eilam, O
    Peacock, M
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A342 - A342
  • [50] Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilizationThe impact oftheboxed warning
    Eworuke, E.
    Popat, V.
    Moeny, D. G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (04) : 483 - 494